Kolmar BioTech Overview

  • Year Founded
  • 1989

Year Founded

  • Status
  • Public

  • Employees
  • 142

Employees

  • Stock Symbol
  • 215380

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $1.31
  • (As of Friday Closing)

Kolmar BioTech General Information

Description

Kolmar BioTech Inc provides biotechnology research and laboratory infrastructure services. Its business activities include supporting biotechnology ventures and startups, operating as a biotechnology incubator and accelerator, providing animal testing services, and offering GMP and cleanroom construction, laboratory construction, maintenance, and laboratory modernization services.

Contact Information

Formerly Known As
Hanwha MGI Special Purpose Acquisition Company, Woojung Bio
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 593-8, Dongtangiheung-ro
  • Hwaseong, Gyeonggi 07325
  • South Korea
+82
Primary Industry
Biotechnology
Stock Exchange
KRX
Corporate Office
  • 593-8, Dongtangiheung-ro
  • Hwaseong, Gyeonggi 07325
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kolmar BioTech Stock Performance

As of 20-Nov-2026, Kolmar BioTech’s stock price is $1.31. Its current market cap is $21.8M with 16.7M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.31 $1.33 $1.15 - $3.07 $21.8M 16.7M 48K -$0.15

Kolmar BioTech Financials Summary

As of 31-Mar-2026, Kolmar BioTech has a trailing 12-month revenue of $28.3M.

In Thousands,
USD
TTM 31-Mar-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 59,556 54,656 51,062 58,432
Revenue 28,267 26,411 31,661 29,535
EBITDA 1,955 738 5,588 1,867
Net Income (2,579) (3,897) 165 (3,865)
Total Assets 80,113 60,274 64,291 76,305
Total Debt 34,778 35,085 34,614 40,597
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Kolmar BioTech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kolmar BioTech‘s full profile, request access.

Request a free trial

Kolmar BioTech Patents

Kolmar BioTech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024128488-A1 Apparatus for vaporizing and decomposing hydrogen peroxide vapor Inactive 15-Dec-2022
US-20250082803-A1 Hydrogen peroxide vaporization and decomposition apparatus Pending 15-Dec-2022
WO-2024117307-A1 Apparatus for vaporizing and decomposing hydrogen peroxide vapor Inactive 30-Nov-2022
WO-2024117768-A1 Hydrogen peroxide vaporizer Inactive 30-Nov-2022
WO-2023249176-A1 Hydrogen peroxide vaporizer Inactive 23-Jun-2022 A61L2/208
To view Kolmar BioTech’s complete patent history, request access »

Kolmar BioTech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kolmar BioTech Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Kolmar BioTech‘s full profile, request access.

Request a free trial

Kolmar BioTech Investments (3)

Kolmar BioTech’s most recent deal was a Corporate Asset Purchase with Korea Land and Housing (Dongtan Urban High-Tech Industrial Complex in Hwaseong, South Korea) for . The deal was made on 26-Sep-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Korea Land and Housing (Dongtan Urban High-Tech Industrial Complex in Hwaseong, South Korea) 26-Sep-2022 Corporate Asset Purchase Buildings and Property
Ab Chem Bio 01-Dec-2021 Seed Round Drug Discovery
CarBio Seed Round Other Healthcare Technology Systems
To view Kolmar BioTech’s complete investments history, request access »

Kolmar BioTech ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Food Products

Industry

Rank

Percentile

Agriculture

Subindustry

Rank

Percentile

To view Kolmar BioTech’s complete esg history, request access »

Kolmar BioTech FAQs

  • When was Kolmar BioTech founded?

    Kolmar BioTech was founded in 1989.

  • Where is Kolmar BioTech headquartered?

    Kolmar BioTech is headquartered in Hwaseong, South Korea.

  • What is the size of Kolmar BioTech?

    Kolmar BioTech has 142 total employees.

  • What industry is Kolmar BioTech in?

    Kolmar BioTech’s primary industry is Biotechnology.

  • Is Kolmar BioTech a private or public company?

    Kolmar BioTech is a Public company.

  • What is Kolmar BioTech’s stock symbol?

    The ticker symbol for Kolmar BioTech is 215380.

  • What is the current stock price of Kolmar BioTech?

    As of 20-Nov-2026 the stock price of Kolmar BioTech is $1.31.

  • What is the current market cap of Kolmar BioTech?

    The current market capitalization of Kolmar BioTech is $21.8M.

  • What is Kolmar BioTech’s current revenue?

    The trailing twelve month revenue for Kolmar BioTech is $28.3M.

  • What is Kolmar BioTech’s annual earnings per share (EPS)?

    Kolmar BioTech’s EPS for 12 months was -$0.15.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process